| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502732A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/20/2004 | US20040097765 Method for the isomerisation of allyl alcohols |
| 05/20/2004 | US20040097749 Reacting 8-bromoquinoline and bis(cyclopentadienyl)cobalt iodide, to form (quinolylcyclopentadiene)(eta-5-cyclopentadien -yl)cobalt(I), then with iron chloride to form 8-quinolylcyclopentadiene; metallocenes |
| 05/20/2004 | US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097554 For therapy and prophylaxis of autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral inflammation, transplantation tissue rejection, atherosclerosis, restenosis |
| 05/20/2004 | US20040097530 Novel heteroaryl derivatives and their use as medicaments |
| 05/20/2004 | US20040097519 Novel salt and crystalline forms of (2r)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber- 5-yl)piperazin-1-yl]- 2-hydroxypropoxy}quinoline |
| 05/20/2004 | US20040097518 For use in therapy and prophylaxis |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097431 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040094769 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds |
| 05/19/2004 | EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor |
| 05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150168C Amphiphili 8-hydroxyquinoline complex, its preparing process |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/13/2004 | WO2004039787A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 05/13/2004 | WO2004039783A1 Quinoline-3-carboxamide compound |
| 05/13/2004 | WO2004039782A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2002072578A3 (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
| 05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092556 Aids therapy |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092401 Plant safening agents |
| 05/13/2004 | US20040089867 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 05/13/2004 | CA2503770A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 05/12/2004 | EP1311485A4 Processes for preparing cilostazol |
| 05/12/2004 | EP1052984B1 Antibacterial agents |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | CN1496354A Quinoline, isoquinoline and phthalazine derivatives as antagonists of gonadotropin-releasing hormone |
| 05/12/2004 | CN1149223C Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149188C Arylaminomethylenecamphor derivatives |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734193 (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity |
| 05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734182 Aryl sulfonamides and sulfamide derivatives and uses thereof |
| 05/11/2004 | US6733905 Metal coordination compound, luminescence device and display apparatus |
| 05/06/2004 | WO2004037853A2 Quinolones with anti-hiv activity |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037796A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 05/06/2004 | WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 05/06/2004 | WO2004037773A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087657 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors |
| 05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
| 05/06/2004 | US20040087618 Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 05/06/2004 | US20040087597 Preventives and remedies for complications of diabetes |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087577 Anti-infective agents |
| 05/06/2004 | US20040087575 Therapeutic chromone compounds |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | EP1414785A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/06/2004 | EP1143923B1 Agent and method for colouring fibres |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | CA2503588A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 05/05/2004 | CN1494531A Process for producing quinoline-3-carboxylic acid compound |
| 05/05/2004 | CN1493562A Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
| 05/05/2004 | CN1148353C Phosphatidase A2 inhibitor and its prepn process and use |
| 05/05/2004 | CN1148352C 6.7-disubstituted-5,8-quinolinedione derivatives as antifungal agent |
| 05/05/2004 | CN1148189C Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
| 05/04/2004 | US6730790 Chlorinated heterocyclic compounds and methods of synthesis |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730682 Herpes virus |
| 05/04/2004 | US6730418 Quinoline derivatives and organic electroluminescent devices |
| 04/29/2004 | WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004034985A2 Chemical compounds |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2003027132A8 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |